Bioequivalence and Bioavailability Forum 04:31 CET

Main page Policy/Terms of Use Abbreviations Latest Posts

 Log in |  Register |  Search

Put the sickle to the corn [General Sta­tis­tics]

posted by Helmut Homepage - Vienna, Austria, 2018-02-13 01:37  - Posting: # 18409
Views: 7,201

Dear Astea,

may I call you Nasty as well?

» I may suppose there were some problems in your Acetylsalicylic acid study - may be in stability…

Samples put in an ice-bath until centrifugation, plasma diluted 1:1 with 5% o-phosphoric acid for stabilization.

» … or inadequate sampling time,

Hhm. 00:05, 00:10, 00:15, 00:20, 00:30, 00:40, 00:50, 01:00, 01:20, 01:40, 02:00, 02:30, 03:00, 04:00, 06:00, 08:00, 10:00, 12:00 hours. No problems with "first point Cmax".

» … did you measure also salicylic acid?

Sure. Nice rho (see in the list above).


» What was the dose?

100 mg ASA (actually 5 × 20 mg tablets).

I recalculated the entire study (October 1997!) from raw-data (nasty!). Maximum residual AUC in any of the 24 subjects 7%. CVintra: ASA 18.3% (Cmax), 11.8% (AUC0–t); SA 9.58% (Cmax), 8.71% (AUC0–t). Both ASA and SA passed BE with flying colors.

Helmut Schütz

The quality of responses received is directly proportional to the quality of the question asked. ☼
Science Quotes

Complete thread:

 Mix view
Bioequivalence and Bioavailability Forum |  Admin contact
19,154 posts in 4,080 threads, 1,308 registered users;
online 6 (0 registered, 6 guests [including 5 identified bots]).

One can show the following: given any rule, however “fundamental”
or “necessary” for science, there are always circumstances
when it is advisable not only to ignore the rule,
but to adopt its opposite.    Paul Feyerabend

BEBAC Ing. Helmut Schütz